Key result
Median pre-dialysis cardiac troponin T levels were higher in patients who experienced 12-month cardiac events compared to those who did not.
Why the study?
The prognostic value of a new sensitive cardiac troponin T assay compared with troponin I and CK-MB in end-stage renal failure patients without acute myocardial infarction was unclear.
Does elevated cardiac troponin T predict 12-month cardiac events in asymptomatic patients with end-stage renal disease on hemodialysis?
Cohort (n=100)
Yes
Does elevated cardiac troponin T predict 12-month cardiac events in asymptomatic patients with end-stage renal disease on hemodialysis?
Elevated cardiac troponin T is a useful prognostic marker for predicting cardiovascular events in asymptomatic hemodialysis patients.
Answers are grounded in this paper and cite their sources.
Troponin T may aid risk stratification in asymptomatic hemodialysis patients; leaves open whether routine use improves outcomes.
Background: Cardiac troponin T (cTnT) is a highly sensitive and specific marker of myocardial damage. The aim of this study was to investigate the prognostic value of a new sensitive TnT assay in comparison with TnI and other cardiac markers. Methods: We measured serial pre- and post-dialysis cTnT, cTnI, and creatine kinase-MB (CK-MB) concentrations in 100 patients with end-stage renal failure without signs of acute myocardial infarction. Sera were analyzed for cardiac troponin T (cTnT) using the Elecsys Analyzer 2010 immunoassay system and for cardiac troponin I (cTnI) using the Immulite automated immunoassay analyzer. Results: There were no significant differences in pre- and post-dialysis values for TnT and TnI (p ≥ 0.05), while CK and CK-MB levels were significantly lower post-dialysis (p ≤ 0.05). Elevated pre-dialysis levels above the upper reference limits were found in 35 patients (35%) with the TnI assay (p ≥ 0.05) and in 65 patients (65%) with the TnT assay (p ≤ 0.05). Conclusions: Elevated troponin T identifies a subgroup of ESRD patients who may be at increased risk of cardiac infarction, even among asymptomatic individuals.
No takes yet. Share an insight, caveat, or question.
Osman et al. (2024) conducted a cohort in End-stage renal disease (ESRD) on hemodialysis (n=100). Elevated pre-dialysis Cardiac Troponin T (cTnT) vs. Normal cTnT levels / other cardiac markers was evaluated on 12-month cardiac events (admission for unstable angina, acute myocardial infarction, or sudden death) (p=≤0.01). Median pre-dialysis cardiac troponin T levels were higher in patients who experienced 12-month cardiac events compared to those who did not.
Synapse has enriched 10 related papers. Consider them for comparative context: